Avid Bioservices Inc (CDMO): << PPHM vs ONTY.....so what makes...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	454
Boards Moderated	0
Alias Born	10/07/2012

investingdog

Re: here4beer post# 115158

Wednesday, 03/06/2013 7:51:31 PM

Wednesday, March 06, 2013 7:51:31 PM

<< PPHM vs ONTY.....so what makes PPHM better than its twin....or worse... >>

Well, you can't be serious - Stimuvax doesn't work.

Dec 19, 2012
"Shares of Oncothyreon shed more than half their value Wednesday after the drug developer said an experimental lung cancer treatment missed its main goal of improving overall survival in a late-stage study.

THE SPARK: The Seattle company said Stimuvax, which is labeled L-BLP25, was tested in patients with an advanced form of non-small cell lung cancer. The study involved more than 1,500 patients in 33 countries.

Oncothyreon said researchers saw "notable treatment effects" in some subgroups of the study, and it will conduct more analysis on that, but the company did not offer details. CEO Robert Kirkman said that the results were disappointing, and he noted the drug has been under development for more than a decade."